Search

Your search keyword '"Claessens, Frank"' showing total 833 results

Search Constraints

Start Over You searched for: Author "Claessens, Frank" Remove constraint Author: "Claessens, Frank"
833 results on '"Claessens, Frank"'

Search Results

2. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

3. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

6. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

7. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

9. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.

10. Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor – substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial

11. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

13. ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

14. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

15. Shared heritability and functional enrichment across six solid cancers.

16. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

19. Androgen deprivation therapy-resistant club cells are linked to myeloid cell-driven immunosuppression in the prostate tumor microenvironment

20. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

21. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

24. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

25. Rational evolution for altering the ligand preference of estrogen receptor alpha.

28. Data from A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

29. Supplementary Figure Legends from A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

30. Figure S4 from A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

32. Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys

33. Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study

34. Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery

36. A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer

37. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

38. Chemoprevention

39. The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis

41. Time to onset of antifracture efficacy and year‐by‐year persistence of effect of zoledronic acid in women with osteoporosis

42. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

46. Adrenal cortex size and homeostasis are regulated by gonadal hormones via androgen receptor/β-catenin signaling crosstalk

47. Abstract 3441: A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity

48. Data from Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer

Catalog

Books, media, physical & digital resources